Molina Healthcare (MOH) Valuation Reassessed After Analyst Downgrades And Mixed Fourth Quarter Results

Simply Wall St

Tue, February 24, 2026 at 7:12 AM GMT+9 3 min read

In this article:

MOH

+3.45%

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Molina Healthcare (MOH) is back in focus after a wave of analyst downgrades following mixed fourth quarter 2025 results and cautious 2026 guidance, which has put its Medicaid profit outlook under closer scrutiny.

See our latest analysis for Molina Healthcare.

Molina Healthcare’s recent volatility stands out, with an 11.56% 7 day share price return and a 1 day gain of 1.86% coming after a 25.21% 30 day share price decline. At the same time, the 1 year total shareholder return of 46.80% and 3 year total shareholder return of 47.44% indicate that longer term momentum has faded despite short term rebounds around earnings, guidance and the completed buyback program.

If cautious sentiment around Molina’s outlook has you reassessing ideas, it could be a good moment to scan 27 healthcare AI stocks for other health related opportunities powered by data and automation.

Molina now trades close to analyst targets, yet its intrinsic discount figure and completed buyback raise fresh questions: is the current weakness a chance to enter, or is the market already pricing in any future recovery?

Most Popular Narrative: 63.3% Undervalued

With Molina Healthcare last closing at $151 and the featured narrative pointing to a fair value of $411.65, the gap between market price and narrative value is wide enough to catch attention and frame the entire debate around what is already in the price.

Catalysts

Read the complete narrative.

Want to see how membership growth, premium assumptions and margin expectations all feed into that valuation gap? The narrative lays out a detailed revenue path, earnings runway and the profit profile underpinning that higher future multiple, but keeps one crucial set of assumptions in plain sight only if you read it in full.

Result: Fair Value of $411.65 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the same user narrative highlights regulatory shifts and unexpected medical cost trends as potential pressure points that could quickly challenge the view that the stock is currently undervalued.

Find out about the key risks to this Molina Healthcare narrative.

Next Steps

If this mix of optimism and caution leaves you on the fence, do not wait for the crowd to decide for you. Instead, check the balance of 3 key rewards and 1 important warning sign and shape your own view.

Story Continues  

Looking for more investment ideas?

If you stop with just one company, you risk missing other opportunities that match your style, so use the Simply Wall Street Screener to broaden your watchlist.

Target income first by checking out 15 dividend fortresses that could help you build a steady cash flow profile from your holdings.

Hunt for potential mispricing with 53 high quality undervalued stocks, where solid fundamentals meet prices that may not fully reflect the underlying business.

Prioritise sleep at night comfort by scanning 85 resilient stocks with low risk scores that score well on resilience and downside protection.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include MOH.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info